Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Prostate Cancer

Free Subscription Articles published in Oncol Rep Retrieve available abstracts of 18 articles: HTML format

Single Articles

May 2026
1. BOKOBZA SM, Ye L, Kynaston HG, Jiang WG, et al
   [Retracted] Growth and differentiation factor?9 promotes adhesive and motile capacity of prostate cancer cells by up?regulating FAK and Paxillin via Smad dependent pathway.
   Oncol Rep. 2026;55:84.
   PubMed     Abstract available
   
   
   
2. KIM K, Lee J, Choi C, Bae J, et al
   Sphingosine?1?phosphate receptor 1 enhances olfactory receptor 51E1?mediated inhibition of proliferation via Src/JNK signaling in prostate cancer cells.
   Oncol Rep. 2026;55:98.
   PubMed     Abstract available
   
   
   April 2026
3. SHEN P, Wang X, Yan X, Du H, et al
   High RMI1 expression is associated with cancer cell progression and poor prognosis in prostate cancer.
   Oncol Rep. 2026;55:55.
   PubMed     Abstract available
   
   
   
4. LAKSHMI PSV, Parashar J, Biswas B, Ummanni R, et al
   Hypoxia?induced miR?135b?5p promotes neuroendocrine differentiation of prostate cancer cells through HIF1AN?HIF1alpha axis.
   Oncol Rep. 2026;55:74.
   PubMed     Abstract available
   
   
   November 2025
5. NAKAYAMA M, Takagi-Maeda S, Machino Y, Nihira K, et al
   Novel tetravalent bispecific antibody, PSMA/TRAIL?R2 REGULGENT, induces selective tumor cell apoptosis without hepatotoxicity.
   Oncol Rep. 2025;54:155.
   PubMed     Abstract available
   
   
   September 2025
6. WU S, Huang J, Hui K, Yue Y, et al
   [Corrigendum] 2'?Hydroxyflavanone inhibits epithelial?mesenchymal transition, and cell migration and invasion via suppression of the Wnt/beta?catenin signaling pathway in prostate cancer.
   Oncol Rep. 2025;54:102.
   PubMed     Abstract available
   
   
   
7. LI YF, Su S, Luo Y, Wei C, et al
   Widespread activation and critical role of EMT and stemness in the neuroendocrine differentiation of prostate cancer (Review).
   Oncol Rep. 2025;54:109.
   PubMed     Abstract available
   
   
   July 2025
8. LIU C, Tang Y, Wang J, Zhou Y, et al
   Effect of Polygonatum Sibiricum polysaccharides on nude mice model of prostate cancer PC?3 cells.
   Oncol Rep. 2025;54:84.
   PubMed     Abstract available
   
   
   April 2025
9. GUO X, Li S
   Bone metastases of prostate cancer: Molecular mechanisms, targeted diagnosis and targeted therapy (Review).
   Oncol Rep. 2025;53:46.
   PubMed     Abstract available
   
   
   February 2025
10. YANG C, Wang L, Gong C, Lv D, et al
    Antibody?drug conjugates in prostate cancer: Emerging strategies to enhance therapeutic index and current clinical landscape (Review).
    Oncol Rep. 2025;53:21.
    PubMed     Abstract available
    
    
    November 2024
11. ZHOU Y, Ji Z, Yan W, Zhou Z, et al
    [Retracted] Tetramethylpyrazine inhibits prostate cancer progression by downregulation of forkhead box M1.
    Oncol Rep. 2024;52:152.
    PubMed     Abstract available
    
    
    October 2024
12. NOURUZI S, Johnson F, Kumar S, Sivak O, et al
    Targeting adenocarcinoma and enzalutamide?resistant prostate cancer using the novel anti?androgen inhibitor ADA?308.
    Oncol Rep. 2024;52:132.
    PubMed     Abstract available
    
    
    June 2024
13. LIU Y, Qin Z, Yang K, Liu R, et al
    [Corrigendum] Cripto?1 promotes epithelial?mesenchymal transition in prostate cancer via Wnt/beta?catenin signaling.
    Oncol Rep. 2024;51:75.
    PubMed     Abstract available
    
    
    
14. PAN J, Tong F, Ren N, Ren L, et al
    Role of N(6)?methyladenosine in the pathogenesis, diagnosis and treatment of prostate cancer (Review).
    Oncol Rep. 2024;51:88.
    PubMed     Abstract available
    
    
    May 2024
15. HSIA YJ, Lin ZM, Zhang T, Chou TC, et al
    Butyrate increases methylglyoxal production through regulation of the JAK2/Stat3/Nrf2/Glo1 pathway in castration?resistant prostate cancer cells.
    Oncol Rep. 2024;51:71.
    PubMed     Abstract available
    
    
    March 2024
16. PARAJULI KR, Jung Y, Taichman RS
    Abscisic acid signaling through LANCL2 and PPARgamma induces activation of p38MAPK resulting in dormancy of prostate cancer metastatic cells.
    Oncol Rep. 2024;51:39.
    PubMed     Abstract available
    
    
    January 2024
17. LEE DY, Chun JN, So I, Jeon JH, et al
    Oncogenic role of FOXM1 in human prostate cancer (Review).
    Oncol Rep. 2024;51:15.
    PubMed     Abstract available
    
    
    December 2023
18. LEE DY, Lee S, Kim YS, Park S, et al
    Cyclosporin A inhibits prostate cancer growth through suppression of E2F8 transcription factor in a MELK?dependent manner.
    Oncol Rep. 2023;50:218.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Prostate Cancer is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum